Cargando…

βKlotho is identified as a target for theranostics in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) remains a great challenge, calling for the identification of novel molecular targets with diagnostic/therapeutic value. Here, we sought to characterize the expression of βKlotho and its anti-tumor roles in NSCLC. Methods: The expression of βKlotho was examined in N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Fan, Li, Xiyao, Li, Ziming, Ji, Wenxiang, Lu, Shun, Xia, Weiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831461/ https://www.ncbi.nlm.nih.gov/pubmed/31695781 http://dx.doi.org/10.7150/thno.35582

Ejemplares similares

βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2023)

Erratum: βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum
por: Li, Fan, et al.
Publicado: (2020)

FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway
por: Ji, Wenxiang, et al.
Publicado: (2016)

Enhanced autocrine FGF19/FGFR4 signaling drives the progression of lung squamous cell carcinoma, which responds to mTOR inhibitor AZD2104
por: Li, Fan, et al.
Publicado: (2020)

Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2019)

Identification of FGF19 as a prognostic marker and potential driver gene of lung squamous cell carcinomas in Chinese smoking patients
por: Tan, Qiang, et al.
Publicado: (2016)

A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling
por: Yuan, Qian, et al.
Publicado: (2022)

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
por: Yuan, Hong, et al.
Publicado: (2017)

Knockdown of CDK5 down-regulates PD-L1 via the ubiquitination-proteasome pathway and improves antitumor immunity in lung adenocarcinoma
por: Gao, Lin, et al.
Publicado: (2021)

Author Correction: A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling
por: Yuan, Qian, et al.
Publicado: (2022)

Overexpression of Klotho Inhibits HELF Fibroblasts SASP-related Protumoral Effects on Non-small Cell Lung Cancer Cells
por: Chen, Bo, et al.
Publicado: (2018)

Adjudin synergizes with paclitaxel and inhibits cell growth and metastasis by regulating the sirtuin 3–Forkhead box O3a axis in human small‐cell lung cancer
por: Wang, Xue, et al.
Publicado: (2019)

SHANK1 facilitates non-small cell lung cancer processes through modulating the ubiquitination of Klotho by interacting with MDM2
por: Chen, Bo, et al.
Publicado: (2022)

Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testing
por: Yu, Yongfeng, et al.
Publicado: (2021)

Small molecules as theranostic agents in cancer immunology
por: Li, Jindian, et al.
Publicado: (2019)

Alpha‐Klotho, a critical protein for lung health, is not expressed in normal lung
por: Zhang, Jianning, et al.
Publicado: (2019)

FGF21 Requires βklotho to Act In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Alignment of Alzheimer’s disease amyloid β-peptide and klotho
por: LEHRER, STEVEN, et al.
Publicado: (2020)

Mitochondria-targeting theranostics
por: Kang, Han Chang
Publicado: (2018)

First‐line crizotinib versus platinum‐pemetrexed chemotherapy in patients with advanced ROS1‐rearranged non‐small‐cell lung cancer
por: Shen, Lan, et al.
Publicado: (2020)

Theranostics application of tumor-initiating cell probe TiY in non-small cell lung cancer
por: Lee, Yong-An, et al.
Publicado: (2023)

Klotho as Potential Autophagy Regulator and Therapeutic Target
por: Zhou, Hongjing, et al.
Publicado: (2021)

SIRT2 inhibits non-small cell lung cancer cell growth through impairing Skp2-mediated p27 degradation
por: Li, Ziming, et al.
Publicado: (2016)

Phosphate and Klotho
por: Kuro-o, Makoto
Publicado: (2011)

Phenotypes of Klotho
por: Sen, Jyoti Misra
Publicado: (2019)

Klotho is upregulated in human cardiomyopathy independently of circulating Klotho levels
por: Poelzl, G., et al.
Publicado: (2018)

Treatment preferences for epidermal growth factor receptor mutation-positive non-small cell lung cancer with brain metastasis: a large-scale survey from Chinese oncologists
por: Yu, Yongfeng, et al.
Publicado: (2022)

Small molecules and conjugates as theranostic agents
por: Pratihar, Sumon, et al.
Publicado: (2023)

Reduced Plasma Levels of α-Klotho and Their Correlation With Klotho Polymorphisms in Elderly Patients With Major Depressive Disorders
por: Gao, Xiang, et al.
Publicado: (2021)

Predictable Roles of Peripheral IgM Memory B Cells for the Responses to Anti-PD-1 Monotherapy Against Advanced Non-Small Cell Lung Cancer
por: Xia, Liliang, et al.
Publicado: (2021)

Cardiomyocyte-targeted and 17β-estradiol-loaded acoustic nanoprobes as a theranostic platform for cardiac hypertrophy
por: Zhao, Xueli, et al.
Publicado: (2018)

Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Targeted theranostic photoactivation on atherosclerosis
por: Song, Joon Woo, et al.
Publicado: (2021)

SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4
por: Li, Ziming, et al.
Publicado: (2018)

FGF23 Actions on Target Tissues—With and Without Klotho
por: Richter, Beatrice, et al.
Publicado: (2018)

Klotho: A new therapeutic target in diabetic retinopathy?
por: Puddu, Alessandra, et al.
Publicado: (2023)

SMO mutation predicts the effect of immune checkpoint inhibitor: From NSCLC to multiple cancers
por: Ji, Wenxiang, et al.
Publicado: (2022)

Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and Klotho
por: Gayan‐Ramirez, Ghislaine, et al.
Publicado: (2021)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cctg9qlratact61c4inbh375b1